214977-38-5

Basic information

• Product Name: (3-BROMO-PYRIDIN-2-YL)-METHYL-AMINE
• Synonyms: (3-BROMO-PYRIDIN-2-YL)-METHYL-AMINE;3-BROMO-2-METHYLAMINOPYRIDINE;3-bromo-N-methylpyridin-2-amine
• CAS NO: 214977-38-5
• Molecular Formula: C₆H₇BrN₂
• Molecular Weight: 187.03718
• Mol File: 214977-38-5.mol

Chemical Properties

• Appearance: /
• Storage Temp.: Inert atmosphere,Room Temperature
• CAS DataBase Reference: (3-BROMO-PYRIDIN-2-YL)-METHYL-AMINE(CAS DataBase Reference)
• NIST Chemistry Reference: (3-BROMO-PYRIDIN-2-YL)-METHYL-AMINE(214977-38-5)
• EPA Substance Registry System: (3-BROMO-PYRIDIN-2-YL)-METHYL-AMINE(214977-38-5)

Safety Data

• Hazardous Substances Data: 214977-38-5(Hazardous Substances Data)

Usage

Uses

Used in Organic Chemistry Research:
(3-BROMO-PYRIDIN-2-YL)-METHYL-AMINE is used as a chemical intermediate for the synthesis of various organic compounds. Its unique structure allows it to be a valuable building block in the development of new molecules with potential applications in different industries.
Used in Pharmaceutical Industry:
(3-BROMO-PYRIDIN-2-YL)-METHYL-AMINE is used as a key component in the design and synthesis of new drug molecules. Its presence in the molecular structure can influence the pharmacological properties, such as solubility, stability, and bioavailability, making it a promising candidate for drug discovery and development.
Used in Material Science:
(3-BROMO-PYRIDIN-2-YL)-METHYL-AMINE is used as a functional group in the creation of new materials with specific properties. Its incorporation into polymers or other materials can lead to enhanced characteristics, such as improved thermal stability, conductivity, or mechanical strength, depending on the application.

Upstream product

• 13534-99-1 2-Amino-3-bromopyridine 
• 74-88-4 methyl iodide 
• 468718-62-9 N-(3-bromo-4-trimethylsilylpyridin-2-yl)-N-methylamine 

Downstream Products

• 521984-94-1 1-methyl-2-phenyl-1H-pyrrolo-[2,3-b]pyridine 
• 1335113-62-6 N-(3-bromopyridin-2-yl)-N-methyl-2-oxo-2-phenylacetamide 

Relevant articles and documents

Hetarynic synthesis and chemical transformation of dihydrodipyridopyrazines

Unprecedented dihydrodipyridopyrazines were easily obtained by hetarynic dimerization of 2-alkylamino-3-halogenopyridines in the presence of the complex base NaNH2-tBuONa. Derivatizations of the new heterocycles are described. The anticancer ac

Efficient synthesis of 3-bromo-2-[(N-substituted)amino]pyridines and their hetarynic cyclization

A variety of 3-bromo-2-[(N-substituted)amino]pyridines were obtained via two convenient methods and were used in the hetarynic synthesis of the corresponding N-substituted dihydro-dipyridopyrazines. Georg Thieme Verlag Stuttgart.

Towards New Tricyclic Motifs: Intramolecular C–H Arylation as the Key Step in a Formal [3+3] Cyclocondensation Strategy

Tricyclic scaffolds structurally related to the well-known benzodiazepine class of drugs show diverse biological activities strikingly different from those of their benzodiazepine counterparts. Interested by this scaffold-hopping perspective, we previousl

Reductive cyclization of halo-ketones to form 3-hydroxy-2-oxindoles via palladium catalyzed hydrogenation: a hydrogen-mediated Grignard addition

Abstract The reductive cyclization of N-oxoacyl ortho-bromoanilides to form 3-hydroxy-2-oxindoles under the conditions of palladium catalyzed hydrogenation is described. This work may be viewed as a prelude to intermolecular hydrogen-mediated Grignard-typ

Synthesis of nitro N,N′-dipyridinylamines via oxidative nucleophilic substitution of hydrogen

The amination of 3-nitropyridines with aromatic amides generated from various aminopyridine derivatives proceeded unexpectedly in the position para to the nitro group, giving the oxidative nucleophilic substitution of hydrogen (ONSH) derived compounds. After optimization, this reaction allowed easy access to interesting 3-nitro-substituted N,N′-dipyridinylamines. Georg Thieme Verlag Stuttgart.

5,10-dihydrodipyrido[2,3-b:2,3-e]pyrazin and 5,10-dihydrodipyrido[2,3-b:3,2-e]pyrazin compounds

A compound selected from those of formula (I): wherein: X represents N, C or CH, Y represents N when X represents C or CH, or Y represents C or CH when X represents N, R1 represents an optionally substituted alkyl, R2 and R3, which may be identical or different, represent Z or W, as defined in the description, their isomers and addition salts thereof with a pharmaceutically-acceptable acid or base, and medicinal products containing the same which are useful in the treatment of cancer.